1,152
Participants
Start Date
March 8, 2022
Primary Completion Date
April 8, 2022
Study Completion Date
No treatment given
Novo Nordisk Investigational Site, Zurich
Lead Sponsor
Novo Nordisk A/S
INDUSTRY